| scholarly article | Q13442814 |
| P2093 | author name string | J M Wells | |
| K Robinson | |||
| R W Le Page | |||
| E Remaut | |||
| K M Schofield | |||
| L Steidler | |||
| L Chamberlain | |||
| P2860 | cites work | High efficiency transformation of E. coli by high voltage electroporation | Q29615278 |
| Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guérin strains that secrete cytokines | Q33591159 | ||
| Expression of the murine interleukin-4 gene in an attenuated aroA strain of Salmonella typhimurium: persistence and immune response in BALB/c mice and susceptibility to macrophage killing | Q33614634 | ||
| Multiple biological activities are expressed by a mouse interleukin 6 cDNA clone isolated from bone marrow stromal cells | Q33650453 | ||
| B cell growth modulating and differentiating activity of recombinant human 26-kd protein (BSF-2, HuIFN-beta 2, HPGF). | Q33930223 | ||
| Interleukin 2 and its receptors: recent advances and new immunological functions | Q34063626 | ||
| Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization | Q34083154 | ||
| Tetanus toxin: primary structure, expression in E. coli, and homology with botulinum toxins | Q34182788 | ||
| PhoP/PhoQ: macrophage-specific modulators ofSalmonellavirulence? | Q34657622 | ||
| Cytokines as adjuvants for vaccines: antigen-specific responses differ from polyclonal responses. | Q35433528 | ||
| Studies of immunity and bacterial invasiveness in mice given a recombinant salmonella vector encoding murine interleukin-6. | Q35505997 | ||
| Molecular and cellular basis of immune protection of mucosal surfaces | Q35531450 | ||
| Cytokines as immunological adjuvants | Q36226512 | ||
| Selective induction of immune responses by cytokines coexpressed in recombinant fowlpox virus. | Q36638003 | ||
| Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas | Q37412328 | ||
| Interleukin-6: an overview | Q37925519 | ||
| Secretion of biologically active murine interleukin-2 by Lactococcus lactis subsp. lactis | Q39797477 | ||
| Genetic marking of Lactococcus lactis shows its survival in the human gastrointestinal tract. | Q39798055 | ||
| Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans. | Q39827320 | ||
| T cell growth factor: parameters of production and a quantitative microassay for activity | Q40680131 | ||
| Lactic acid bacteria as vaccine delivery vehicles | Q41174265 | ||
| Cytokine-containing liposomes as vaccine adjuvants. | Q41332034 | ||
| Immunoadjuvant activity of a liposomal IL-6 formulation | Q41584026 | ||
| Cloning of usp45, a gene encoding a secreted protein from Lactococcus lactis subsp. lactis MG1363. | Q42630460 | ||
| Receptors for B cell stimulatory factor 2. Quantitation, specificity, distribution, and regulation of their expression | Q42938866 | ||
| Modulation of antiviral immune responses by exogenous cytokines: effects of tumour necrosis factor-alpha, interleukin-1 alpha, interleukin-2 and interferon-gamma on the immunogenicity of an inactivated rabies vaccine | Q44050254 | ||
| Intranasal immunization with liposomes containing IL-2 enhances bacterial polysaccharide antigen-specific pulmonary secretory antibody response | Q44618966 | ||
| T cell unresponsiveness to the mitogenic activity of OKT3 antibody results from a deficiency of monocyte Fc gamma receptors for murine IgG2a and inability to cross-link the T3-Ti complex | Q45083864 | ||
| The role of interleukin-6 in mucosal IgA antibody responses in vivo | Q45872747 | ||
| Unique structure of murine interleukin-2 as deduced from cloned cDNAs | Q48382302 | ||
| Expression of human IL-1 beta in Salmonella typhimurium. A model system for the delivery of recombinant therapeutic proteins in vivo | Q50180383 | ||
| In vivo adjuvant effect of interleukins 5 and 6 on rat tear IgA antibody responses. | Q52098735 | ||
| An interleukin-6 transgene expressed in B lymphocyte lineage cells overcomes the T cell-dependent establishment of normal levels of switched immunoglobulin isotypes. | Q53805508 | ||
| Improved cloning vectors and transformation procedure for Lactococcus lactis. | Q54656595 | ||
| Serum interleukin-6 concentrations are elevated and associated with elevated tumor necrosis factor-α and immunoglobulin G and A concentrations in children with HIV infection | Q67819563 | ||
| Detection of IL-6 in human milk and its involvement in IgA production | Q68072384 | ||
| High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production | Q69230503 | ||
| What is BCG? | Q70446694 | ||
| Modifications of the follicle-associated epithelium by short-term exposure to a non-intestinal bacterium | Q71870910 | ||
| The effects of transforming growth factor‐ and interleukins 2,5 and 6 on immunoglobulin production in cultured rat salivary gland tissues | Q72060690 | ||
| Study of gene transfer in vitro and in the digestive tract of gnotobiotic mice from Lactococcus lactis strains to various strains belonging to human intestinal flora | Q72705197 | ||
| Lactococcus lactis: high-level expression of tetanus toxin fragment C and protection against lethal challenge | Q72903201 | ||
| Protection against tetanus toxin in mice nasally immunized with recombinant Lactococcus lactis expressing tetanus toxin fragment C | Q73403518 | ||
| Oral vaccination of mice against tetanus with recombinant Lactococcus lactis | Q73502185 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Lactococcus lactis | Q133598 |
| P304 | page(s) | 3183-3189 | |
| P577 | publication date | 1998-07-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine | |
| P478 | volume | 66 |
| Q91687884 | A Review of the Microbial Production of Bioactive Natural Products and Biologics |
| Q33676056 | A foreign protein incorporated on the Tip of T3 pili in Lactococcus lactis elicits systemic and mucosal immunity |
| Q37736878 | A review on Lactococcus lactis: from food to factory |
| Q40409120 | Ability of Lactococcus lactis to export viral capsid antigens: a crucial step for development of live vaccines |
| Q33613453 | Adjuvant effects for oral immunization provided by recombinant Lactobacillus casei secreting biologically active murine interleukin-1{beta} |
| Q90732045 | Analysis of Immune Responses in Mice Orally Immunized with Recombinant pMG36e-SP-TSOL18/Lactococcus lactis and pMG36e-TSOL18/Lactococcus lactis Vaccines of Taenia solium |
| Q39490225 | Bovine rotavirus nonstructural protein 4 produced by Lactococcus lactis is antigenic and immunogenic. |
| Q37054925 | Characterization of a Lactococcus lactis strain that secretes a major epitope of bovine beta-lactoglobulin and evaluation of its immunogenicity in mice |
| Q36067915 | Comparative genome-based identification of a cell wall-anchored protein from Lactobacillus plantarum increases adhesion of Lactococcus lactis to human epithelial cells |
| Q36191696 | Construction and immunological evaluation of dual cell surface display of HIV-1 gag and Salmonella enterica serovar Typhimurium FliC in Lactobacillus acidophilus for vaccine delivery |
| Q37914007 | Cytokines: the future of intranasal vaccine adjuvants. |
| Q39775001 | Determination of the domain of the Lactobacillus delbrueckii subsp. bulgaricus cell surface proteinase PrtB involved in attachment to the cell wall after heterologous expression of the prtB gene in Lactococcus lactis |
| Q33920554 | Development of recombinant vaccines in lactobacilli for elimination of salmonella |
| Q35946659 | Effects of intranasal administration of a leptin-secreting Lactococcus lactis recombinant on food intake, body weight, and immune response of mice. |
| Q49339110 | Engineering bacteria for diagnostic and therapeutic applications |
| Q41853924 | Enhanced secretion of biologically active murine interleukin-12 by Lactococcus lactis |
| Q38116457 | IL-1Ra and its delivery strategies: inserting the association in perspective. |
| Q24804214 | In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii |
| Q33999105 | Induction of mucosal immune response after intranasal or oral inoculation of mice with Lactococcus lactis producing bovine beta-lactoglobulin |
| Q35143128 | Innate endogenous adjuvants prime to desirable immune responses via mucosal routes |
| Q28660843 | Intranasal immunization with recombinant Lactococci carrying human papillomavirus E7 protein and mouse interleukin-12 DNA induces E7-specific antitumor effects in C57BL/6 mice |
| Q39741884 | Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production. |
| Q35193105 | Lactic acid bacteria--20 years exploring their potential as live vectors for mucosal vaccination |
| Q39639957 | Lactobacillus bulgaricus proteinase expressed in Lactococcus lactis is a powerful carrier for cell wall-associated and secreted bovine beta-lactoglobulin fusion proteins |
| Q35596025 | Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines |
| Q34974711 | Live bacterial vaccines--a review and identification of potential hazards |
| Q90735919 | Mucosal Vaccination with Lactococcus lactis-Secreting Surface Immunological Protein Induces Humoral and Cellular Immune Protection against Group B Streptococcus in a Murine Model |
| Q37427432 | Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C. |
| Q24799750 | Mucosal delivery of anti-inflammatory IL-1Ra by sporulating recombinant bacteria |
| Q37111626 | Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria |
| Q35838661 | Mucosal immunity: overcoming the barrier for induction of proximal responses. |
| Q42018536 | Nisin-controlled extracellular production of interleukin-2 in Lactococcus lactis strains, without the requirement for a signal peptide sequence |
| Q34344893 | Novel xylan-controlled delivery of therapeutic proteins to inflamed colon by the human anaerobic commensal bacterium |
| Q36045824 | Oral Immunization of BALB/c Mice with Giardia duodenalis Recombinant Cyst Wall Protein Inhibits Shedding of Cysts |
| Q51748194 | Oral delivery of glucagon like peptide-1 by a recombinant Lactococcus lactis. |
| Q34100066 | Production of human papillomavirus type 16 E7 protein in Lactococcus lactis |
| Q24808692 | Protein secretion in Lactococcus lactis : an efficient way to increase the overall heterologous protein production |
| Q27028100 | Recombinant Lactococcus lactis can make the difference in antigen-specific immune tolerance induction, the Type 1 Diabetes case |
| Q33990262 | Signal peptide and propeptide optimization for heterologous protein secretion in Lactococcus lactis |
| Q39329973 | Surface display of N-terminally anchored invasin by Lactobacillus plantarum activates NF-κB in monocytes |
| Q35881190 | Surface display of glycosylated Tyrosinase related protein-2 (TRP-2) tumour antigen on Lactococcus lactis |
| Q34993580 | Surface display of the receptor-binding region of the Lactobacillus brevis S-layer protein in Lactococcus lactis provides nonadhesive lactococci with the ability to adhere to intestinal epithelial cells |
| Q40050837 | The combination of recombinant and non-recombinant Bacillus subtilis spore display technology for presentation of antigen and adjuvant on single spore |
| Q34057292 | The peptidyl-prolyl isomerase motif is lacking in PmpA, the PrsA-like protein involved in the secretion machinery of Lactococcus lactis |
Search more.